- ►diabetesjournals.org J Koska, A DelParigi, B de Courten, C Weyer, … - Diabetes, 2004 - Am Diabetes Assoc Pancreatic polypeptide (PP) is released from the pancreas in response to a meal.
In humans, low-circulating PP levels have been observed in obesity, and
administration of pharmacological doses of PP has been shown to decrease ... Cited by 16 - Related articles - BL Direct - All 5 versions
T Reinehr, PJ Enriori, K Harz, MA Cowley, CL … - International Journal of Obesity, 2006 - nature.com Obese children had significantly (P<0.01) lower PP, and higher leptin and
insulin levels compared to lean children. In multiple linear regression
analysis, PP was significantly negatively correlated to body mass index ... Cited by 5 - Related articles - BL Direct - All 5 versions
TH Moran - Gastroenterology, 2003 - Elsevier The demonstration by Asakawa et al.[1] that pancreatic polypeptide (PP) inhibits
food intake and stimulates energy expenditure following its peripheral
administration adds yet another putative peptide signaling molecule to the ... Cited by 11 - Related articles - BL Direct - All 6 versions
O Pieramico, P Malfertheiner, DK Nelson, B … - International journal of obesity, 1990 - ncbi.nlm.nih.gov Changes in pancreatic polypeptide plasma concentrations have been reported in
obesity. It has been suggested that altered PP plasma levels may play a role in
the abnormal food intake observed in obesity. Earlier studies, however, ... Cited by 6 - Related articles - All 2 versions
- ►nih.gov - Free from Publisher JJ Hwang, JL Chan, G Ntali, D Malkova, CS … - Diabetes care, 2008 - Am Diabetes Assoc RESULTS—Amylin and pancreatic polypeptide levels increased 15 min after a 75-g
glucose load and remained elevated at 60 and 120 min (P < 0.0001). Fasting for
72 h decreased leptin (to 21%) and amylin (to 67%) of baseline but not ... Cited by 2 - Related articles - BL Direct - All 6 versions
C Weyer, AD Salbe, RS Lindsay, RE Pratley, … - Metabolism, 2001 - Elsevier Vagally-mediated hyperinsulinemia is a common abnormality in various rodent
models of genetic and hypothalamic obesity that have a high propensity for type
2 diabetes. We hypothesized that Pima Indians, a population with a high ... Cited by 24 - Related articles - BL Direct - All 7 versions
A Balasubramaniam, DE Mullins, S Lin, W Zhai … - Journal of medicinal chemistry, 2006 - ncbi.nlm.nih.gov We have previously shown [Cys-Trp-Arg-Nva-Arg-Tyr-NH(2)](2), 1, to be a
moderately selective neuropeptide Y (NPY) Y(4) receptor agonist. Toward
improving the selectivity and potency for Y(4) receptors, we studied the ... Cited by 11 - Related articles - All 5 versions
TA Larsson, ET Larson, R Fredriksson, JM … - Peptides, 2006 - Elsevier We report the cloning and pharmacological characterization of two neuropeptide Y
(NPY) receptor subtypes, Y2 and Y7, in rainbow trout (Oncorhynchus mykiss).
These subtypes are approximately 50% identical to each other and belong to ... Cited by 6 - Related articles - All 3 versions
T Wultsch, E Painsipp, S Donner, G Sperk, H … - Behavioural Brain Research, 2006 - Elsevier Neuropeptide-Y (NPY) is involved in the regulation of ingestive behaviour and
energy homeostasis. Since deletion of the NPY Y2 and Y4 receptor gene increases
and decreases food intake, respectively, we examined whether water intake ... Cited by 6 - Related articles - All 3 versions
